Transforming Growth Factor-b1 polymorphism is not associated with chronic graft disease: evidence from a meta-analysis

Lima, Bruno A.; Alves, Helena

http://hdl.handle.net/10400.18/3969

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
TRANSFORMING GROWTH FACTOR-B1.pdf		220.55 KB	Adobe PDF	Download

Send Feedback

Authors

Lima, Bruno A.

Alves, Helena

Abstract(s)

Kidney transplantation has been recognised as the optimal treatment choice for most end stage renal disease patients and the increase of allograft survival rates is achieved through the refinement of novel immunosuppressive agents. Chronic Graft Disease (CGD) is a multifactorial process that likely includes a combination of immunological, apoptotic and inflammatory factors. The application of individualised immunosuppressive therapies will also depend on the identification of risk factors that can influence chronic disease. Despite being the subject of several independent studies, investigations of the relationship between transforming growth factor-b1 (TGF-b1) polymorphisms and kidney graft outcome continue to be plagued by contradictory conclusions.